Krister Wennerberg

Krister Wennerberg

Professor

Member of:

    ORCID: 0000-0002-1352-4220

    Publication year:
    All
    21 - 30 out of 122Page size: 10
    1. 2021
    2. Published

      Selective drug combination vulnerabilities in STAT3- And TP53-mutant malignant NK cells

      Parri, E., Kuusanmäki, Heikki Aleksi, Bulanova, Daria, Mustjoki, S. & Wennerberg, Krister, 2021, In: Blood advances. 5, 7, p. 1862-1875

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments

      Talwelkar, S. S., Mäyränpää, M. I., Søraas, L., Potdar, S., Bao, J., Hemmes, A., Linnavirta, N., Lømo, J., Räsänen, J., Knuuttila, A., Wennerberg, Krister & Verschuren, E. W., 2021, In: Cell Reports Medicine. 2, 8, 21 p., 100373.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Exploration of databases and methods supporting drug repurposing: A comprehensive survey

      Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, Krister, Tang, J. & Vähä-Koskela, M., 2021, In: Briefings in Bioinformatics. 22, 2, p. 1656-1678 23 p.

      Research output: Contribution to journal › Review › Research › peer-review

    5. Published

      Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia

      White, B. S., Khan, S. A., Mason, M. J., Ammad-ud-din, M., Potdar, S., Malani, D., Kuusanmäki, Heikki Aleksi, Druker, B. J., Heckman, C., Kallioniemi, O., Kurtz, S. E., Porkka, K., Tognon, C. E., Tyner, J. W., Aittokallio, T., Wennerberg, Krister & Guinney, J., 2021, In: n p j Precision Oncology. 5, 1, 11 p., 71.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. 2020
    7. Published

      Improved detection of differentially represented DNA barcodes for high-throughput clonal phenomics

      Akimov, Y., Bulanova, Daria, Timonen, S., Wennerberg, Krister & Aittokallio, T., 2020, In: Molecular Systems Biology. 16, 3, p. 1-18 e9195.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Abstract P6-10-28: Therapeutic stratification of triple negative breast cancer by integrating chemosensitivity & phospho-proteome profiles

      Gautam, P., Qin, X., Vainonen, J., Nagelli, S., Lampe, J., Klefström, J., Westermarck, J., Wennerberg, Krister & Aittokallio, T., 2020.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    9. Published

      A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening

      Gupta, A., Gautam, P., Wennerberg, Krister & Aittokallio, T., 2020, In: Communications Biology. 3, 1, p. 1-12

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

      Hansson, K., Radke, K., Aaltonen, K., Saarela, J., Mañas, A., Sjölund, J., Smith, E. M., Pietras, K., Påhlman, S., Wennerberg, Krister, Gisselsson, D. & Bexell, D., 2020, In: Science Translational Medicine. 12, 562, p. 1-17 eaba4434.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. Published

      Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer

      Hobbs, G. A., Baker, N. M., Miermont, A. M., Thurman, R. D., Pierobon, M., Tran, T. H., Anderson, A. O., Waters, A. M., Diehl, J. N., Papke, B., Hodge, R. G., Klomp, J. E., Goodwin, C. M., DeLiberty, J. M., Wang, J., Ng, R. W. S., Gautam, P., Bryant, K. L., Esposito, D., Campbell, S. L. & 8 others, Petricoin, E. F., Simanshu, D. K., Aguirre, A. J., Wolpin, B. M., Wennerberg, Krister, Rudloff, U., Cox, A. D. & Der, C. J., 2020, In: Cancer Discovery. 10, 1, p. 104-123 20 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

      Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, Krister, Hautaniemi, S. & Carpén, O., 2020, In: Journal of Pathology. 250, 2, p. 159-169 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 4 5 6 7 8 ...13 Next

    ID: 181406515